Efficacy of full-dose TCA injection vs half dose in patients with DQST

Efficacy of Low-dose (Half Dose) Triamcinolone Acetate Injection Compared to Full-Dose: A non-inferiority Randomized Controlled Trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20260405005

Enrollment

Registered

2026-04-05

Start date

2026-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

De quervain&#039

Interventions

Injection by half dose TCA for patients with DQST,Standard dose for TCA injection for DQST patients

Experimental Drug,Active Comparator Drug

Half Dose TCA injection,Full Dose TCA

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. age >18 2. diagnosed with de quervain's tenosynositis from clinical 3. never been treated for quervain's tenosynositis prior to enrollment 4. available for 6 week followup

Exclusion criteria

Exclusion criteria: 1. Contraindicated for corticosteroid injection 2.Previously treated for De Quervain's tenosynovitis by steroid injection/surgery prior to this visit 3.Traumatic/malignancy cause for wrist pain 4. not available for follow up 6. open wound/infection at injection site

Design outcomes

Primary

Measure	Time frame
Pain score 6 week post-injection Visual Numerical Rating Score (VNRS score)	—

Secondary

Measure	Time frame
Function outcome 6 week post-injection Quick- Disabilities of the Arm, Shoulder and Hand Score (Quick-DASH score),Adverse outcomes 6 week post-injection -	—

Countries

Thailand

Contacts

Public ContactNattan Tangakavachiranon

Department of Orthopedics, King Chulalongkorn Memorial Hospital

tanattan.2012@gmail.com022564510

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026